Zeo ScientifiX ZEOX
OTC ZEOX
$1.42 +0.07 (+5.19%)
At close: Aug 20, 2026 · 4:00 PM EDT

Zeo ScientifiX (ZEOX) Cash & Current Investments (2013 - 2026)

Zeo ScientifiX (ZEOX) posted quarterly Cash & Current Investments of $1.8 million for Q2 2026, up 240.59% year-over-year from $542000.0 in Q2 2025, and up 79.22% quarter-over-quarter from $1.0 million in Q1 2026.

Zeo ScientifiX (ZEOX) Cash & Current Investments (2013 - 2026) Analysis & Trends

Zeo ScientifiX's Cash & Current Investments history runs 14 years deep, the most recent figure standing at $1.8 million for Q2 2026.

  • In Q2 2026, Cash & Current Investments rose 240.59% year-over-year to $1.8 million; the TTM figure through Apr 2026 stood at $1.8 million (up 240.59% YoY), while the FY2025 annual figure was $221000.0, down 66.36% from the prior year.
  • Cash & Current Investments for Q2 2026 stood at $1.8 million, up from $1.0 million in the prior quarter.
  • The five-year high for Cash & Current Investments was $3.8 million in Q4 2022, with the low at $66002.0 in Q2 2022.
  • The 5-year median for Cash & Current Investments is $733000.0 (2024), against an average of $959721.5.
  • The sharpest annual moves came in 2022 and 2025: Cash & Current Investments surged 3356.76% in 2022, then slumped 77.38% in 2025.
  • Zeo ScientifiX's Cash & Current Investments stood at $3.8 million in 2022, then sank by 53.21% to $1.8 million in 2023, then slumped by 62.59% to $657000.0 in 2024, then plunged by 66.36% to $221000.0 in 2025, then surged by 735.29% to $1.8 million in 2026.
  • Business Quant data shows ZEOX's Cash & Current Investments at $1.8 million in Q2 2026, $1.0 million in Q1 2026, and $221000.0 in Q4 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 7.85 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 7.99 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 5.18 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 5.14 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 3.31 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 18.39 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 1.16 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 836.99 Mn
10 Zeo ScientifiX 10.51 Mn 8.67 Mn 2.06 Mn 1.85 Mn

Historic Data

Download Data
DateValue
Apr 30, 2026 1.85 Mn
Jan 31, 2026 1.03 Mn
Oct 31, 2025 221,000.00
Jul 31, 2025 250,000.00
Apr 30, 2025 542,000.00
Jan 31, 2025 720,000.00
Oct 31, 2024 657,000.00
Jul 31, 2024 1.11 Mn
Apr 30, 2024 746,000.00
Jan 31, 2024 1.17 Mn
Oct 31, 2023 1.76 Mn
Jul 31, 2023 633,000.00
Apr 30, 2023 1.13 Mn
Jan 31, 2023 1.42 Mn
Oct 31, 2022 3.75 Mn
Jul 31, 2022 74,665.00
Apr 30, 2022 66,002.00
Jan 31, 2022 150,320.00
Oct 31, 2021 108,570.00
Jul 31, 2021 29,207.00